Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based studyJavier Garciá Corbacho, Francesco Schettini, Esther Sanfeliu et al.|Cancer Immunology Immunotherapy|2023Cited by 19
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckSara I. Pai, Norah J. Shire, Ezra E.W. Cohen et al.|Journal of Translational Medicine|2019Cited by 11
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal studyJavier Garciá Corbacho, Francesco Schettini, Alberto Indacochea et al.|Cancer Immunology Immunotherapy|2025Cited by 3
Sex differences in laryngeal cancer treated with CO2-transoral laser microsurgery: a case-control studyIsabel Vilaseca, Manuel Bernal‐Sprekelsen, Claudio Sampieri et al.|European Archives of Oto-Rhino-Laryngology|2025Cited by 0